Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
niclosamide
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Generic mfg.
Drug class:
mTOR inhibitor, STAT3 inhibitor, Notch inhibitor
Related drugs:
‹
everolimus (138)
RTB101 (43)
temsirolimus (37)
PF-05212384 (31)
sirolimus (20)
GSK2126458 (17)
AZD8055 (10)
sirolimus (8)
PF-04691502 (6)
LY3023414 (5)
GDC-0980 (4)
phenformin (4)
AZD2014 (4)
CC-115 (3)
RapaLink-1 (3)
GDC-0084 (3)
AVTX-006 (2)
ME-344 (2)
PI-103 (2)
Torin1 (2)
PP242 (2)
DFN-529 (1)
EC-70124 (1)
QL-VIII-58 (1)
CBL0102 (1)
AUM302 (0)
BGT226 (0)
DS-3078 (0)
DS-7423 (0)
DTRM-555 (0)
ETP-47187 (0)
HEC68498 (0)
IBL-301 (0)
MKC-1 (0)
rapamycin topical (0)
SF1126 (0)
sirolimus (0)
ridaforolimus (0)
VCD-597 (0)
VS-5584 (0)
XL388 (0)
PQR309 (0)
NSC311152 (0)
encapsulated rapamycin (0)
everolimus (0)
SVG101 (0)
ABTL0812 (0)
inhibitors of the PI3K/AKT/mTOR pathway (0)
KD 032 (0)
albumin-bound (0)
SAR245409 (0)
BBI608 (4)
BP1003 (2)
NT-157 (2)
TTI-101 oral (2)
JSI-124 (2)
INB03 (1)
YHO-1701 (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
SHR0302 (0)
VT-11CR (0)
AL101 (1)
CB-103 (1)
PF‐06293622 (1)
RG4733 (1)
MK-0752 (0)
Notch Inhibitor (0)
OMP-52M51 (0)
LY3039478 (0)
AL102 (0)
everolimus (138)
RTB101 (43)
temsirolimus (37)
PF-05212384 (31)
sirolimus (20)
GSK2126458 (17)
AZD8055 (10)
sirolimus (8)
PF-04691502 (6)
LY3023414 (5)
GDC-0980 (4)
phenformin (4)
AZD2014 (4)
CC-115 (3)
RapaLink-1 (3)
GDC-0084 (3)
AVTX-006 (2)
ME-344 (2)
PI-103 (2)
Torin1 (2)
PP242 (2)
DFN-529 (1)
EC-70124 (1)
QL-VIII-58 (1)
CBL0102 (1)
AUM302 (0)
BGT226 (0)
DS-3078 (0)
DS-7423 (0)
DTRM-555 (0)
ETP-47187 (0)
HEC68498 (0)
IBL-301 (0)
MKC-1 (0)
rapamycin topical (0)
SF1126 (0)
sirolimus (0)
ridaforolimus (0)
VCD-597 (0)
VS-5584 (0)
XL388 (0)
PQR309 (0)
NSC311152 (0)
encapsulated rapamycin (0)
everolimus (0)
SVG101 (0)
ABTL0812 (0)
inhibitors of the PI3K/AKT/mTOR pathway (0)
KD 032 (0)
albumin-bound (0)
SAR245409 (0)
BBI608 (4)
BP1003 (2)
NT-157 (2)
TTI-101 oral (2)
JSI-124 (2)
INB03 (1)
YHO-1701 (1)
stattic (1)
CM-728 (0)
DUET-101 (0)
DUET-201 (0)
GLG-302 (0)
HJC0152 (0)
NT219 (0)
OPB-111077 (0)
STAT3 inhibitor (0)
sulforafan alfadex (0)
WP1066 (0)
SK&F106615 (0)
iMX-110 (0)
AZD9150 (0)
ACT001 (0)
BS-HH-002.SA (0)
SHR0302 (0)
VT-11CR (0)
AL101 (1)
CB-103 (1)
PF‐06293622 (1)
RG4733 (1)
MK-0752 (0)
Notch Inhibitor (0)
OMP-52M51 (0)
LY3039478 (0)
AL102 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
niclosamide
Sensitive: D – Preclinical
niclosamide
Sensitive
:
D
niclosamide
Sensitive: D – Preclinical
niclosamide
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login